{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:39:50Z","timestamp":1771925990158,"version":"3.50.1"},"reference-count":76,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T00:00:00Z","timestamp":1315267200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0001302","type":"journal-article","created":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T20:42:02Z","timestamp":1315341722000},"page":"e1302","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":49,"title":["Meningococcal Factor H Binding Proteins in Epidemic Strains from Africa: Implications for Vaccine Development"],"prefix":"10.1371","volume":"5","author":[{"given":"Rolando","family":"Pajon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"Fergus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Koeberling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique A.","family":"Caugant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan M.","family":"Granoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,9,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0035-9203(99)90106-2","article-title":"Manson Lecture. Meningococcal meningitis in Africa.","volume":"93","author":"B Greenwood","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00006454-199912000-00005","article-title":"Evaluation of meningococcal meningitis vaccination strategies for the meningitis belt in Africa.","volume":"18","author":"MA Miller","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"ref3","first-page":"645","article-title":"A second controlled field trial of a serogroup A meningococcal polysaccharide vaccine in Alexandria.","volume":"55","author":"MH Wahdan","year":"1977","journal-title":"Bull World Health Organ"},{"key":"ref4","first-page":"667","article-title":"A controlled field trial of a serogroup A meningococcal polysaccharide vaccine.","volume":"48","author":"MH Wahdan","year":"1973","journal-title":"Bull World Health Organ"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/00034983.1983.11811694","article-title":"Failure of meningococcal vaccination to stop the transmission of meningococci in Nigerian schoolboys.","volume":"77","author":"IS Blakebrough","year":"1983","journal-title":"Ann Trop Med Parasitol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1001\/jama.1988.03410180094036","article-title":"Group A meningococcal carriage in travelers returning from Saudi Arabia.","volume":"260","author":"PS Moore","year":"1988","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0140-6736(02)08416-7","article-title":"Development of vaccines against meningococcal disease.","volume":"359","author":"L Jodar","year":"2002","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.vaccine.2008.11.065","article-title":"Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa.","volume":"27","author":"CH Lee","year":"2009","journal-title":"Vaccine"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"B13","DOI":"10.1016\/j.vaccine.2009.04.062","article-title":"Epidemic meningitis due to Group A <italic>Neisseria meningitidis<\/italic> in the African meningitis belt: a persistent problem with an imminent solution.","volume":"27","author":"F Marc LaForce","year":"2009","journal-title":"Vaccine"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1003812","article-title":"Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans.","volume":"364","author":"SO Sow","year":"2011","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1586\/14760584.5.3.319","article-title":"Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.","volume":"5","author":"JE Mueller","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/511646","article-title":"Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger.","volume":"44","author":"P Boisier","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1365-3156.2005.01520.x","article-title":"Emergence of W135 meningococcal meningitis in Ghana.","volume":"10","author":"AA Forgor","year":"2005","journal-title":"Trop Med Int Health"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1086\/339010","article-title":"Prospective study of a serogroup X <italic>Neisseria meningitidis<\/italic> outbreak in northern Ghana.","volume":"185","author":"SP Gagneux","year":"2002","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1128\/JCM.01495-08","article-title":"B:2a:p1.5 meningococcal strains likely arisen from capsular switching event still spreading in Spain.","volume":"47","author":"J Castilla","year":"2009","journal-title":"J Clin Microbiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S1473-3099(06)70584-9","article-title":"No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales.","volume":"6","author":"CL Trotter","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(02)08679-8","article-title":"Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.","volume":"359","author":"MC Maiden","year":"2002","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1542\/peds.2004-2338","article-title":"Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004.","volume":"116","author":"SS Huang","year":"2005","journal-title":"Pediatrics"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.297.16.1784","article-title":"Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.","volume":"297","author":"RJ Singleton","year":"2007","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/j.1651-2227.2010.01914.x","article-title":"Rebound in the incidence of pneumococcal meningitis in northern France: effect of serotype replacement.","volume":"99","author":"C Alexandre","year":"2010","journal-title":"Acta Paediatr"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.epidem.2010.03.005","article-title":"Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete.","volume":"2","author":"WP Hanage","year":"2010","journal-title":"Epidemics"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3201\/eid1609.100102","article-title":"Pneumococcal serotypes in children in 4 European countries.","volume":"16","author":"G Hanquet","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1086\/648966","article-title":"Review of meningococcal group B vaccines.","volume":"50","author":"DM Granoff","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/erv.10.3","article-title":"The epidemiology of meningococcal disease and the impact of vaccines.","volume":"9","author":"A Khatami","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.vaccine.2005.11.006","article-title":"Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens.","volume":"24","author":"S Jacobsson","year":"2006","journal-title":"Vaccine"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.vaccine.2010.11.072","article-title":"Distribution of factor H binding protein beyond serogroup B: variation among five serogroups of invasive <italic>Neisseria meningitidis<\/italic> in South Africa.","volume":"29","author":"KM Mothibeli","year":"2011","journal-title":"Vaccine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against <italic>Neisseria meningitidis<\/italic> using three variants of the lipoprotein GNA1870.","volume":"197","author":"V Masignani","year":"2003","journal-title":"J Exp Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the <italic>Neisseria meningitidis<\/italic> 2086 lipoprotein.","volume":"72","author":"LD Fletcher","year":"2004","journal-title":"Infect Immun"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus.","volume":"103","author":"MM Giuliani","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.vaccine.2010.06.083","article-title":"Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease.","volume":"28","author":"HQ Jiang","year":"2010","journal-title":"Vaccine"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.vaccine.2010.12.039","article-title":"A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression.","volume":"29","author":"PB Keiser","year":"2011","journal-title":"Vaccine"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1016\/j.vaccine.2010.05.006","article-title":"Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine.","volume":"28","author":"WD Zollinger","year":"2010","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1016\/j.vaccine.2011.04.095","article-title":"Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeys.","volume":"29","author":"O Koeberling","year":"2011","journal-title":"Vaccine"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1128\/CVI.00542-10","article-title":"A critical threshold of meningococcal factor h binding protein expression is required for increased breadth of protective antibodies elicited by native outer membrane vesicle vaccines.","volume":"18","author":"O Koeberling","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CVI.00403-08","article-title":"Meningococcal outer membrane vesicle vaccines derived from mutant strains engineered to express factor H binding proteins from antigenic variant groups 1 and 2.","volume":"16","author":"O Koeberling","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1086\/432102","article-title":"Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870.","volume":"192","author":"VC Hou","year":"2005","journal-title":"J Infect Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","article-title":"The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance.","volume":"177","author":"G Madico","year":"2006","journal-title":"J Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.4049\/jimmunol.176.12.7566","article-title":"Functional significance of factor H binding to <italic>Neisseria meningitidis<\/italic>.","volume":"176","author":"MC Schneider","year":"2006","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/IAI.01191-08","article-title":"Binding of complement factor H (fH) to <italic>Neisseria meningitidis<\/italic> is specific for human fH and inhibits complement activation by rat and rabbit sera.","volume":"77","author":"DM Granoff","year":"2009","journal-title":"Infect Immun"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1128\/IAI.00033-08","article-title":"Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines.","volume":"76","author":"PT Beernink","year":"2008","journal-title":"Infect Immun"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1128\/CVI.00007-09","article-title":"Ex vivo model of meningococcal bacteremia using human blood for measuring vaccine-induced serum passive protective activity.","volume":"16","author":"JS Plested","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/656741","article-title":"Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.","volume":"51","author":"J Findlow","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1097\/INF.0b013e3181f59f6d","article-title":"Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial.","volume":"29","author":"MD Snape","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1128\/IAI.00367-08","article-title":"Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor H-binding protein.","volume":"76","author":"PT Beernink","year":"2008","journal-title":"Infect Immun"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1086\/528994","article-title":"Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen.","volume":"197","author":"JA Welsch","year":"2008","journal-title":"J Infect Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","article-title":"Human immunity to the meningococcus. II. Development of natural immunity.","volume":"129","author":"I Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1016\/j.vaccine.2006.03.091","article-title":"<italic>Neisseria meningitidis<\/italic> group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005.","volume":"24","author":"R Borrow","year":"2006","journal-title":"Vaccine"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"B112","DOI":"10.1016\/j.vaccine.2009.04.065","article-title":"Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease.","volume":"27","author":"CE Frasch","year":"2009","journal-title":"Vaccine"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1086\/597806","article-title":"Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa.","volume":"199","author":"PT Beernink","year":"2009","journal-title":"J Infect Dis"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.vaccine.2009.12.027","article-title":"Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates.","volume":"28","author":"R Pajon","year":"2010","journal-title":"Vaccine"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1086\/589308","article-title":"Bactericidal antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed factor H-binding protein and genetically attenuated endotoxin.","volume":"198","author":"O Koeberling","year":"2008","journal-title":"J Infect Dis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3201\/eid1004.030247","article-title":"PorA variable regions of <italic>Neisseria meningitidis<\/italic>.","volume":"10","author":"JE Russell","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1099\/mic.0.029876-0","article-title":"The modular architecture of meningococcal factor H-binding protein.","volume":"155","author":"PT Beernink","year":"2009","journal-title":"Microbiology"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.vaccine.2006.03.092","article-title":"Improved immunogenicity of a H44\/76 group B outer membrane vesicle vaccine with over-expressed genome-derived Neisserial antigen 1870.","volume":"25","author":"O Koeberling","year":"2007","journal-title":"Vaccine"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.4049\/jimmunol.1003470","article-title":"A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination.","volume":"186","author":"PT Beernink","year":"2011","journal-title":"J Immunol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.4049\/jimmunol.172.9.5606","article-title":"Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a <italic>Neisseria meningitidis<\/italic> candidate vaccine.","volume":"172","author":"JA Welsch","year":"2004","journal-title":"J Immunol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.4049\/jimmunol.160.10.5028","article-title":"Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid.","volume":"160","author":"DM Granoff","year":"1998","journal-title":"J Immunol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1128\/JCM.43.10.5129-5135.2005","article-title":"Molecular epidemiology of <italic>Neisseria meningitidis<\/italic> isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes.","volume":"43","author":"P Nicolas","year":"2005","journal-title":"J Clin Microbiol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1128\/JCM.44.3.861-871.2006","article-title":"Characterization of <italic>Neisseria meningitidis<\/italic> isolates from recent outbreaks in Ethiopia and comparison with those recovered during the epidemic of 1988 to 1989.","volume":"44","author":"G Norheim","year":"2006","journal-title":"J Clin Microbiol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.vaccine.2010.12.075","article-title":"Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and Neisserial heparin binding antigen.","volume":"29","author":"DM Vu","year":"2011","journal-title":"Vaccine"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1371\/journal.pmed.0040101","article-title":"Clonal waves of Neisseria colonisation and disease in the African meningitis belt: eight- year longitudinal study in northern Ghana.","volume":"4","author":"J Leimkugel","year":"2007","journal-title":"PLoS Med"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"A8","DOI":"10.1016\/j.vaccine.2007.04.033","article-title":"Molecular surveillance of meningococcal meningitis in Africa.","volume":"25","author":"DA Caugant","year":"2007","journal-title":"Vaccine"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1086\/600141","article-title":"Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B <italic>Neisseria meningitidis<\/italic>.","volume":"200","author":"E Murphy","year":"2009","journal-title":"J Infect Dis"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1128\/IAI.00891-10","article-title":"Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies.","volume":"79","author":"KL Seib","year":"2011","journal-title":"Infect Immun"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1128\/CVI.00125-08","article-title":"<italic>Neisseria meningitidis<\/italic> PorB, a Toll-like receptor 2 ligand, improves the capacity of <italic>Francisella tularensis<\/italic> lipopolysaccharide to protect mice against experimental tularemia.","volume":"15","author":"D Chiavolini","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/CVI.00529-09","article-title":"Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity.","volume":"17","author":"H Campbell","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction.","volume":"364","author":"CL Trotter","year":"2004","journal-title":"Lancet"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/CVI.00384-09","article-title":"Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and <italic>Haemophilus influenzae<\/italic> type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine.","volume":"17","author":"R Borrow","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1086\/652765","article-title":"Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial.","volume":"50","author":"KP Perrett","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"8297","DOI":"10.1074\/jbc.M110.184838","article-title":"Meningococcal group W-135 and Y capsular polysaccharides paradoxically enhance activation of the alternative pathway of complement.","volume":"286","author":"S Ram","year":"2011","journal-title":"J Biol Chem"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1128\/CVI.00549-10","article-title":"Measurement of functional anti-meningococcal serogroup A activity using strain 3125 as the target strain for serum bactericidal assay.","volume":"18","author":"JT Poolman","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0161-5890(99)00114-5","article-title":"The contrasting mechanisms of serum resistance of <italic>Neisseria gonorrhoeae<\/italic> and group B <italic>Neisseria meningitidis<\/italic>.","volume":"36","author":"S Ram","year":"1999","journal-title":"Mol Immunol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"e1001027","DOI":"10.1371\/journal.ppat.1001027","article-title":"The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement.","volume":"6","author":"LA Lewis","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1128\/IAI.60.12.5267-5282.1992","article-title":"Clonal and antigenic analysis of serogroup A <italic>Neisseria meningitidis<\/italic> with particular reference to epidemiological features of epidemic meningitis in the People&apos;s Republic of China.","volume":"60","author":"JF Wang","year":"1992","journal-title":"Infect Immun"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1073\/pnas.95.6.3140","article-title":"Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms.","volume":"95","author":"MC Maiden","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"6390","DOI":"10.1128\/jb.177.22.6390-6400.1995","article-title":"The physical map of the chromosome of a serogroup A strain of <italic>Neisseria meningitidis<\/italic> shows complex rearrangements relative to the chromosomes of the two mapped strains of the closely related species N. gonorrhoeae.","volume":"177","author":"JA Dempsey","year":"1995","journal-title":"J Bacteriol"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0001302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:47:36Z","timestamp":1712796456000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0001302"}},"subtitle":[],"editor":[{"given":"Sharon J.","family":"Peacock","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,9,6]]},"references-count":76,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2011,9,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0001302","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,6]]}}}